Undifferentiated Pleomorphic Sarcoma  Can respond to checkpoint blockade like pembrolizumab

Undifferentiated Pleomorphic Sarcoma Can respond to checkpoint blockade like pembrolizumab

User Photo
Annual-Meeting

2 years
159 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Seth M. Pollack, MD, Fred Hutchinson Cancer Research Center, explains Undifferentiated Pleomorphic Sarcoma Can respond to checkpoint blockade like pembrolizumab at Annual Meeting 2018
Up Next Autoplay